Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | — | 637.7B | 802.5B | 712.4B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | 9.7B | 6.8B | 6.1B |
| Other operating expenses | — | 4.2B | 6.1B | 6.4B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | 6.5B | 3.5B | 3.4B |
| Other income expense | — | 158.9B | -81.7B | 93.2B |
| Pretax income | 144.8B | -116.8B | 141.6B | 67.5B |
| Tax provision | 25.2B | -25.7B | 31.1B | 8.6B |
| Net income | 119.6B | -91.1B | 110.4B | 59.0B |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | -91.1B | 90.8B | 59.0B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |